Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 23, Art. 2 (pp. 20-33)    |    2022       

»

Covid-19-infection: psychoneurological disorders in the dynamics of the disease

I.M. Ulyukin, A.A. Sechin, E.S. Orlova, A.A. Shuklina

Kirov Military Medical Academy of Russian Federation Defense Ministry

Brief summary

The review analyzes publications on the characteristics of neuropsychiatric disorders in the dynamics of COVID-19 infection in order to provide effective medical and psychological support for young people during their follow-up and medical and psychological support. Due to the increasing number of reports of central nervous system damage in COVID-19, the current epidemic is likely to be accompanied by a significant increase in the prevalence of individuals with long-term cognitive dysfunction, affecting the ability of the convalescent to return to daily life, which requires an integrated approach to rehabilitation measures


Key words

young people, pandemic, SARS-CoV, COVID-19, central nervous system damage, neuropsychiatric disorders, rehabilitation, medical and psychological support.

Reference list

1. Sypotnickii, M.V. Pandemiya COVID-19 kak indikator «belih pyaten» v epidemiologii i infekcionnoi patologii / M.V. Sypotnickii // Vestnik voisk RHB zashiti. − 2020. − T. 4. 3. − S. 338-373.


2. Wilson, B.A. Neuropsychological consequences of Covid-19 / B.A. Wilson, S. Betteridge, J. Fish // Neuropsychological Rehabilitation. - 2020. - Vol. 30, 9. - R. 1625-1628.


3. Wu, A. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China / A. Wu, Y. Peng, B. Huang [et al.] // Cell Host Microbe. - 2020. − Vol. 27, 3. - P. 325-328.


4. Tsai, L.K. Neurological manifestations in severe acute respiratory syndrome / L.K. Tsai, S.T. Hsieh, Y.C. Chang // Acta Neurol.Taiwan. - 2005. − Vol. 14, 3. - P. 113-19.


5. Saad, M. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia / M. Saad, A.S. Omrani, K. Baig [et al.] // Int. J. Infect. Dis. - 2014. − 29. - P. 301-06.


6. Bohmwald, K. Neurologic Alterations Due to Respiratory Virus Infections / K. Bohmwald, N.M.S. Gálvez, M. Ríos, A.M. Kalergis // Front. Cell Neurosci. - 2018. − 12. - P. 386.


7. Gu, J. Multiple organ infection and the pathogenesis of SARS / J. Gu, E. Gong, B. Zhang [et al.] // J. Exp. Med. - 2005. − Vol. 202, 3. - P. 415-24.


8. Arabi, Y.M. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) / Y.M. Arabi, A. Harthi, J. Hussein [et al.] // Infection. - 2015. − Vol. 43, 4. - P. 495-501.


9. Tansey, C.M. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome / C.M. Tansey, M. Louie, M. Loeb [et al.] // Arch. Intern. Med. - 2007. − Vol. 167, 12. - P. 1312-20.


10. Ngai, J.C. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status / J.C. Ngai, F.W. Ko, S.S. Ng [et al.] // Respirology. - 2010. − Vol. 15, 3. - P. 543-550.


11. Kim, J.E. Neurological Complications during Treatment of Middle East Respiratory Syndrome / J.E. Kim, J.H. Heo, H.O. Kim [et al.] // J. Clin. Neurol. - 2017. − Vol. 13, 3. - P. 227-233.


12. Zanin, L. SARS-CoV-2 can induce brain and spine demyelinating lesions / L. Zanin, G. Saraceno, P.P. Panciani [et al.] // Acta Neurochir. (Wien). - 2020. − Vol. 162, 7. - P. 1491-1494.


13. Klein, R.S. Infectious immunity in the central nervous system and brain function / R.S. Klein, C. Garber, N. Howard // Nat. Immunol. - 2017. − Vol. 18, 2. - P. 132-141.


14. Moriguchi, T. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 / T. Moriguchi, N. Harii, J. Goto [et al.] // Int. J. Infect. Dis. - 2020. − 94. - P. 55-58.


15. Xu, Z. Pathological findings of COVID-19 associated with acute respiratory distress syndrome / Z. Xu, L. Shi, Y. Wang [et al.] // Lancet Respir. Med. - 2020. − Vol. 8, 4. - P. 420-422.


16. Gandhi, S. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients / S. Gandhi, A.K. Srivastava, U. Ray, P.P. Tripathi // ACS Chem. Neurosci. - 2020. − Vol. 11, 10. - P. 1379-1381.


17. Li, Y.C. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients / Y.C. Li, W.Z. Bai, T. Hashikawa // J. Med. Virol. - 2020. − Vol. 92, 6. - P. 552-555.


18. Mao, L. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China / L. Mao, H. Jin, M. Wang [et al.] // JAMA Neurol. - 2020. − Vol. 77, 6. - P. 683-690.


19. Ellul, M.A. Neurological associations of COVID-19 / M.A. Ellul, L. Benjamin, B. Singh [et al.] // Lancet Neurol. - 2020. − Vol. 19, 9. - P. 767-783.


20. Caso, F. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? / F. Caso, L. Costa, P. Ruscitti [et al.] //Autoimmun. Rev. - 2020. − Vol. 19, 5. - P. 102524.


21. Ashrafi, F. COVID-19-related strokes in adults below 55 years of age: a case series / F. Ashrafi, A. Zali, D. Ommi [et al.] // Neurol Sci. - 2020. − Vol. 41, 8. - P. 1985-1989.


22. Giacomelli, A. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study / A. Giacomelli, L. Pezzati, F. Conti [et al.] // Clin. Infect. Dis. - 2020. − Vol. 71, 15. - P. 889-890.


23. Cherry, G. Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends / G. Cherry, J. Rocke, M. Chu [et al.] // Expert Rev. Anti. Infect. Ther. - 2020. − Vol.18, 11. - P. 1165-1170.


24. Rhea, E.M. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice / E.M. Rhea, A.F. Logsdon, K.M. Hansen [et al.] // Nat. Neurosci. - 2021. − Vol. 24, 3. - P. 368-378.


25. Ritchie, K. The cognitive consequences of the COVID-19 epidemic: collateral damage? / K. Ritchie, D. Chan, T. Watermeyer // Brain Commun. - 2020. − Vol. 2, 2. − fcaa069.


26. Jacomy, H. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice / H. Jacomy, G. Fragoso, G. Almazan [et al.] // Virology. - 2006. − Vol. 349, 2. - P. 335-46.


27. Sy, M. Inflammation induced by infection potentiates tau pathological features in transgenic mice / M. Sy, M. Kitazawa, R. Medeiros [et al.] // Am. J. Pathol. - 2011. − Vol. 178, 6. - P. 2811-22.


28. Hosseini, S. Long-Term Neuroinflammation Induced by Influenza A Virus Infection and the Impact on Hippocampal Neuron Morphology and Function / S. Hosseini, E. Wilk, K. Michaelsen-Preusse [et al.] //J. Neurosci. - 2018. − Vol. 38, 1−2. - P. 3060-3080.


29. Netland, J. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2 / J. Netland, D.K. Meyerholz, S. Moore [et al.] // J. Virol. - 2008. − Vol. 82, 15. - P. 7264-75.


30. Kleiton de Sousa, A. SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier / A. Kleiton de Sousa, D. de Aguiar Magalhães, J. dos Santos Ferreira. A.L. dos Reis Barbosa // Medical Hypotheses. - 2020. − 144. - P. 110213.


31. Wu, Y. Nervous system involvement after infection with COVID-19 and other coronaviruses / Y. Wu, X. Xu, Z. Chen [et al.] // Brain Behav. Immun. - 2020. − 87. - P. 18-22.


32. Chen, C. [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019] / C. Chen, X.R. Zhang, Z.Y. Ju, W.F. He // Zhonghua Shao Shang Za Zhi. - 2020. − Vol. 36, 6. - P. 471-475 [Article in Chinese].


33. Mehta, P. COVID-19: consider cytokine storm syndromes and immunosuppression / P. Mehta, D.F. McAuley, M. Brown [et al.] // Lancet. - 2020. − Vol. 395, 10229. - P. 1033-1034.


34. Fazzini, E. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease / E. Fazzini, J. Fleming, S. Fahn // Mov. Disord. - 1992. − Vol. 7, 2. - P. 153-8.


35. Filatov, A. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy / A. Filatov, P. Sharma, F. Hindi, P.S. Espinosa // Cureus. - 2020. − Vol. 12, 3. − e7352.


36. Zhao, H. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? / H. Zhao, D. Shen, H. Zhou [et al.] // Lancet Neurol. - 2020. − Vol. 19, 5. - P. 383-384.


37. Li, H. Involvement of the Nervous System in SARS-CoV-2 Infection / H. Li, Q. Xue, X. Xu // Neurotox. Res. - 2020. − Vol. 38, 1. - P. 1-7.


38. Du, L. A report of 4 cases of severe acute respiratory syndrome patients with suicide tendency / L. Du, J. Zhao, Y. Shi [et al.] // Academic Journal of Second Military Medical University. - 2003. − 24. - P. 636-637.


39. Jeong, H. Mental health status of people isolated due to Middle East Respiratory Syndrome / H. Jeong, H.W. Yim, Y.J. Song [et al.] // Epidemiol. Health. - 2016. − 38. − e2016048.


40. Mak, I.W.C. Long-term psychiatric morbidities among SARS survivors / I.W.C. Mak, C.M. Chu, P.C. Pan [et al.] // Gen. Hosp. Psychiatry. - 2009. − Vol. 31, 4. - P. 318-26.


41. Wing, Y.K. Mental health impact of severe acute respiratory syndrome: a prospective study / Y.K. Wing, C.M. Leung // Hong Kong Med. J. - 2012. − Vol. 18, S.3. - P. 24-7.


42. Daussy, H. Réactivations postgrippales de la psychose maniaque dépressive [Post-influenzal reactivation of manic depressive psychosis] / H. Daussy, F. Mars // Ann. Med. Psychol. (Paris). - 1953. − Vol. 111, 25. - P. 667-672 [Article in French].


43. Fabiani, P. Varie sindromi neuropsichiatriche post-influenzali [Various post-influenzal neuropsychiatric syndromes] / P. Fabiani, L. Mazzanti // Riv. Patol. Nerv. Ment. - 1959. − 80. - P. 402-414 [Article in Italian].


44. Okusaga, O. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts / O. Okusaga, R.H. Yolken, P, Langenberg [et al.] // J. Affect. Disord. - 2011. − Vol. 130, 1-2. - P. 220-225.


45. Brooks, S.K. The psychological impact of quarantine and how to reduce it: rapid review of the evidence / S.K. Brooks, R.K. Webster, L.E. Smith [et al.] // Lancet. − 2020. − Vol. 395, 10227. - P. 912-920.


46. Shoib, S. Factors associated with COVID-19 outbreak-related suicides in India / S. Shoib, S. Nagendrappa, O. Grigo [et al.] // Asian J. Psychiatr. - 2020. − 53. - P. 102223.


47. Mirza, J. Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report / J. Mirza, A. Ganguly, A, Ostrovskaya [et al.] // Psychosomatics. - 2020. − Vol. 61, 5. - P. 561-564.


48. Panico, F. Balint-Holmes syndrome due to stroke following SARS-CoV-2 infection: a single-case report / F. Panico, A. Arini, P. Cantone [et al.] // Neurol. Sci. - 2020. − Vol. 41, 12. - P. 3487-3489.


49. Louapre, C. Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis / C. Louapre, N. Collongues, B. Stankoff [et al.] // JAMA Neurol. - 2020. − Vol. 77, 9. - P. 1079-1088.


50. Lechien, J.R. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019 / J.R. Lechien, C.M. Chiesa-Estomba, S. Place [et al.] // J. Intern. Med. - 2020/ − Vol. 288, − 3. - P. 335-344.


51. Lapostolle, F. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study / F. Lapostolle, E. Schneider, I. Vianu [et al.] // Intern. Emerg. Med. - 2020. − Vol. 15, 5. - P. 813-817.


52. Goërtz, Y.M.J. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? / Y.M.J. Goërtz, M. Van Herck, J.M. Delbressine [et al.] // ERJ Open Res. - 2020. − Vol. 6, 4. - P. 00542-2020.


53. Carfì, A. Persistent Symptoms in Patients After Acute COVID-19 / A. Carfì, R. Bernabei, F. Landi // JAMA. - 2020. - Vol. 324, 6. - P. 603-605.


54. Belli, S. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalization / S. Belli, B. Balbi, I. Prince [et al.] // Eur. Respir. J. - 2020. − Vol. 56, 4. - P. 2002096.


55. Ritchie, K. The cognitive consequences of the COVID-19 epidemic: collateral damage / K. Ritchie, D. Chan, T. Watermeyer // Brain Commun. - 2020. − Vol. 2, 2. − fcaa069.


56. Sun, J. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment / J. Sun, Z. Zhuang, J. Zheng [et al.] // Cell. - 2020. − Vol. 182, 3. - P. 734-743.


57. Simpson, R. Rehabilitation After Critical Illness in People With COVID-19 Infection / Simpson R., Robinson L. // Am. J. Phys. Med. Rehabil. - 2020. − Vol. 99, 6. - P. − 470-474.


58. Klok, F.A. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 / F.A. Klok, G.J.A.M. Boon, S. Barco [et al.] // Eur. Respir. J. - 2020. − Vol. 56, 1. - P. 2001494.


59. Koller, D. Multimorbidity and long-term care dependency − A five-year follow-up / D. Koller, G. Schön, I. Schäfer [et al.] // BMC Geriatr. - 2014. − 14. - P. 70.


60. Steenblock, C. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis / C. Steenblock, V. Todorov, W. Kanczkowski [et al.] // Mol. Psychiatry. - 2020. − Vol. 25, 8. - P. 1611-1617.